The role of death domain proteins in host response upon SARS-CoV-2 infection: modulation of programmed cell death and translational applications

• Published in: Cell death discovery 2020-10, Vol.6 (1), p.101-101, Article 101
• Main Authors: Ivanisenko, Nikita V., Seyrek, Kamil, Kolchanov, Nikolay A., Ivanisenko, Vladimir A., Lavrik, Inna N.
• Format: Article
• Language: English
• Subjects: 631/80/82; 692/420/254; 692/420/256/2177; Apoptosis; Biochemistry; Biomedical and Life Sciences; Cell Biology; Cell Cycle Analysis; Life Sciences; Review; Review Article; Stem Cells
• ISSN: 2058-7716; 2058-7716
• DOI: 10.1038/s41420-020-00331-w

The current pandemic of novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) poses a significant global public health threat. While urgent regulatory measures in control of the rapid spread of this virus are essential, scientists around the world have quickly engaged in this battle by studying the molecular mechanisms and searching for effective therapeutic strategies against this deadly disease. At present, the exact mechanisms of programmed cell death upon SARS-CoV-2 infection remain to be elucidated, though there is increasing evidence suggesting that cell death pathways play a key role in SARS-CoV-2 infection. There are several types of programmed cell death, including apoptosis, pyroptosis, and necroptosis. These distinct programs are largely controlled by the proteins of the death domain (DD) superfamily, which play an important role in viral pathogenesis and host antiviral response. Many viruses have acquired the capability to subvert the program of cell death and evade the host immune response, mainly by virally encoded gene products that control cell signaling networks. In this mini-review, we will focus on SARS-CoV-2, and discuss the implication of restraining the DD-mediated signaling network to potentially suppress viral replication and reduce tissue damage.